Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can positive affect buffer PTSD?: A comparison of dynamic networks during active conflict versus relative calm in war-exposed civilians.

Journal of anxiety disorders·2026
Same author

An exploratory randomized, double-blind trial of accelerated deep TMS for patients with suicidal thoughts and behaviors.

Journal of affective disorders·2025
Same author

Perceptions About Care and Support Among Cancer Survivors With Severe Mental Health Conditions.

Psycho-oncology·2025
Same author

Predicting satisfaction with vocational status among people with serious mental illness in vocational services: the role of perceived skills and support.

Frontiers in psychiatry·2025
Same author

Comparing outcomes of psychiatric rehabilitation between ethnic-religious groups in Israel.

Transcultural psychiatry·2024
Same author

Momentary stress-induced food craving: An ecological momentary assessment study comparing perceived interpersonal and non-interpersonal stressors.

Stress and health : journal of the International Society for the Investigation of Stress·2024

Related Experiment Videos

Nonmedication smoking reduction program for inpatients with chronic schizophrenia: a randomized control design study.

Marc Gelkopf1, Sigalit Noam, Dimitri Rudinski

  • 1Department of Community Mental Health, University of Haifa, Haifa, Israel. emgelkopf@013.net.il

The Journal of Nervous and Mental Disease
|February 3, 2012
PubMed
Summary

Behavioral interventions significantly reduced smoking in hospitalized schizophrenia patients. This smoking reduction did not negatively impact clinical status or weight.

Related Experiment Videos

Area of Science:

  • Psychiatry
  • Addiction Medicine
  • Behavioral Health

Background:

  • Individuals with schizophrenia exhibit higher smoking rates than the general population.
  • Hospitalized patients with schizophrenia smoke more frequently than community-dwelling individuals.
  • Smoking cessation is a significant challenge in schizophrenia treatment.

Purpose of the Study:

  • To assess the efficacy of a behavioral group smoking reduction intervention for chronic hospitalized schizophrenia patients.
  • To evaluate the intervention's impact on smoking behavior, clinical status, quality of life, and weight.

Main Methods:

  • A controlled study randomly assigned chronic schizophrenia inpatients to a five-session smoking reduction intervention or a waiting list.
  • Self-reported smoking, clinical status (using PANSS, HAM-D, CGI-P), quality of life (Q-LES-Q-SV), and weight were assessed pre- and post-intervention (3 months).

Main Results:

  • The intervention group showed a significant reduction in the number of cigarettes smoked compared to the waiting list group.
  • No significant worsening in clinical status (psychosis, depression) was observed.
  • No significant weight gain was associated with the intervention.

Conclusions:

  • Behavioral group-oriented smoking reduction interventions are effective in reducing smoking among hospitalized chronic schizophrenia patients.
  • These interventions can be implemented without adverse effects on clinical status or weight.
  • Smoking reduction programs should be considered for this vulnerable population.